These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 15281114)
1. Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of factor VIII. Kelley BD; Tannatt M; Magnusson R; Hagelberg S; Booth J Biotechnol Bioeng; 2004 Aug; 87(3):400-12. PubMed ID: 15281114 [TBL] [Abstract][Full Text] [Related]
2. Application of a novel affinity adsorbent for the capture and purification of recombinant factor VIII compounds. McCue JT; Selvitelli K; Walker J J Chromatogr A; 2009 Nov; 1216(45):7824-30. PubMed ID: 19800068 [TBL] [Abstract][Full Text] [Related]
3. Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor. Oh HK; Lee JM; Byun TH; Park SY; Kim YH Biotechnol Prog; 2001; 17(6):1119-27. PubMed ID: 11735450 [TBL] [Abstract][Full Text] [Related]
4. Isolation of a peptide ligand for affinity purification of factor VIII using phage display. Kelley BD; Booth J; Tannatt M; Wub QL; Ladner R; Yuc J; Potter D; Ley A J Chromatogr A; 2004 Jun; 1038(1-2):121-30. PubMed ID: 15233528 [TBL] [Abstract][Full Text] [Related]
5. Development of a peptidomimetic ligand for efficient isolation and purification of factor VIII via affinity chromatography. Knör S; Khrenov AV; Laufer B; Saenko EL; Hauser CA; Kessler H J Med Chem; 2007 Sep; 50(18):4329-39. PubMed ID: 17691762 [TBL] [Abstract][Full Text] [Related]
6. A novel, Q-PCR based approach to measuring endogenous retroviral clearance by capture protein A chromatography. Zhang M; Lute S; Norling L; Hong C; Safta A; O'Connor D; Bernstein LJ; Wang H; Blank G; Brorson K; Chen Q Biotechnol Bioeng; 2009 Apr; 102(5):1438-47. PubMed ID: 18988264 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes. Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156 [TBL] [Abstract][Full Text] [Related]
8. One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry. Jacobsen B; Gårdsvoll H; Juhl Funch G; Ostergaard S; Barkholt V; Ploug M Protein Expr Purif; 2007 Apr; 52(2):286-96. PubMed ID: 17027282 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A. Nord K; Nord O; Uhlén M; Kelley B; Ljungqvist C; Nygren PA Eur J Biochem; 2001 Aug; 268(15):4269-77. PubMed ID: 11488921 [TBL] [Abstract][Full Text] [Related]
10. Immobilised peptide displaying phages as affinity ligands. Purification of lactoferrin from defatted milk. Noppe W; Plieva FM; Galaev IY; Vanhoorelbeke K; Mattiasson B; Deckmyn H J Chromatogr A; 2006 Jan; 1101(1-2):79-85. PubMed ID: 16216254 [TBL] [Abstract][Full Text] [Related]
11. Novel peptide ligand with high binding capacity for antibody purification. Lund LN; Gustavsson PE; Michael R; Lindgren J; Nørskov-Lauritsen L; Lund M; Houen G; Staby A; St Hilaire PM J Chromatogr A; 2012 Feb; 1225():158-67. PubMed ID: 22251884 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)]. Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353 [TBL] [Abstract][Full Text] [Related]
13. Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics. Strauss DM; Lute S; Tebaykina Z; Frey DD; Ho C; Blank GS; Brorson K; Chen Q; Yang B Biotechnol Bioeng; 2009 Oct; 104(2):371-80. PubMed ID: 19575414 [TBL] [Abstract][Full Text] [Related]
14. Screening for peptide affinity ligands on CIM monoliths. Pflegerl K; Podgornik A; Berger E; Jungbauer A Biotechnol Bioeng; 2002 Sep; 79(7):733-40. PubMed ID: 12209796 [TBL] [Abstract][Full Text] [Related]
16. Single step purification of plasmid DNA using peptide ligand affinity chromatography. Han Y; Forde GM J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):21-6. PubMed ID: 18815078 [TBL] [Abstract][Full Text] [Related]
17. [Development of a new hydrophobic interaction chromatography absorbent and its application to the purification of recombinant hepatitis B surface antigen]. Wang YM; Bi JX; Zhao L; Zhou WB; Li Y; Huang YD; Zhang Y; Lin H; Su ZG Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):278-84. PubMed ID: 16607957 [TBL] [Abstract][Full Text] [Related]
18. Weak partitioning chromatography for anion exchange purification of monoclonal antibodies. Kelley BD; Tobler SA; Brown P; Coffman JL; Godavarti R; Iskra T; Switzer M; Vunnum S Biotechnol Bioeng; 2008 Oct; 101(3):553-66. PubMed ID: 18727127 [TBL] [Abstract][Full Text] [Related]
19. Use of ceramic monoliths as stationary phase in affinity chromatography. Martin del Valle E; Galan Serrano MA; Cerro RL Biotechnol Prog; 2003; 19(3):921-7. PubMed ID: 12790658 [TBL] [Abstract][Full Text] [Related]
20. Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII. Farrugia A Australas Biotechnol; 1993; 3(1):16-20. PubMed ID: 7763537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]